Here are 10 orthopedic and spine device companies that received financing during 2012. If you would like to add a company to this list, please contact Laura at lmiller@beckershealthcare.com.
AxioMed, a spinal orthopedics company, raised $5 million to complete its Series D financing that supports its Freedom Lumbar Disc, currently on the European market and advancing toward completion of the investigational device exemption study in the U.S.
Benvenue Medical System, a developer of minimally invasive solutions for spine repair, completed a $25 million Series D round of financing to sustain global commercialization of its three products and bring its fusion and VCF products to the U.S. market.
Cayenne Medical, a sports medicine device company, closed $10 million equity financing with Fletcher Spaght Ventures to support the company’s sales and distribution team and expand its product portfolio.
Cerapedics has received $19 million private equity financing from new investors, which will support the company’s activities with the ongoing clinical trial of the i-FACTOR peptide enhanced bone graft for cervical spine surgery.
IlluminOss Medical, a photodynamic orthopedic implants manufacturer, secured $28 million in Series C round of venture capital financing as it pursues the minimally invasive IlluminOss Photodynamic Bone Stabilization System to treat fractures through a small entry into the bone.
Interventional Spine raised $1.6 million after receiving FDA approval for its PerX360 system for spinal fusion.
Lanx raised $8.7 million toward its target of $15.1 million to boost sales of the Timberline Lateral Fusion System and introduce four to six new products in 2013.
Mazor Robotic entered into a financing agreement for $15 million from a group of institutional and accredited investors led by Oracle Investment Management to further investment capital and facilitate the company’s efforts to implement an American Depositary Receipt program on a U.S. stock exchange.
Minimus Spine has received $1 million in financing from 19 investors, which will support the company’s ozone injection technology to treat herniated discs. Minimus Spine also secured $520,000 angel financing to pursue certification of its spinal injection system.
Regentis Biomaterials, a company focused on developing proprietary hydrogels for tissue regeneration, raised $10 million in financing from new investors Royal DSM through its venturing subsidiary, Crossroad Fund, Medica Venture Partners, SCPVitalife and Technion Investment Opportunities Fund to establish a European presence and expand ongoing clinical efforts with GelrinC.
More Articles on Orthopedic Devices:
Smith & Nephew CFO to Resign
Recall Issued for Medtronic Infusion Pumps
Ohio Third Frontier Gives $3M to Medical Device Partnership Fund
Benvenue Medical System, a developer of minimally invasive solutions for spine repair, completed a $25 million Series D round of financing to sustain global commercialization of its three products and bring its fusion and VCF products to the U.S. market.
Cayenne Medical, a sports medicine device company, closed $10 million equity financing with Fletcher Spaght Ventures to support the company’s sales and distribution team and expand its product portfolio.
Cerapedics has received $19 million private equity financing from new investors, which will support the company’s activities with the ongoing clinical trial of the i-FACTOR peptide enhanced bone graft for cervical spine surgery.
IlluminOss Medical, a photodynamic orthopedic implants manufacturer, secured $28 million in Series C round of venture capital financing as it pursues the minimally invasive IlluminOss Photodynamic Bone Stabilization System to treat fractures through a small entry into the bone.
Interventional Spine raised $1.6 million after receiving FDA approval for its PerX360 system for spinal fusion.
Lanx raised $8.7 million toward its target of $15.1 million to boost sales of the Timberline Lateral Fusion System and introduce four to six new products in 2013.
Mazor Robotic entered into a financing agreement for $15 million from a group of institutional and accredited investors led by Oracle Investment Management to further investment capital and facilitate the company’s efforts to implement an American Depositary Receipt program on a U.S. stock exchange.
Minimus Spine has received $1 million in financing from 19 investors, which will support the company’s ozone injection technology to treat herniated discs. Minimus Spine also secured $520,000 angel financing to pursue certification of its spinal injection system.
Regentis Biomaterials, a company focused on developing proprietary hydrogels for tissue regeneration, raised $10 million in financing from new investors Royal DSM through its venturing subsidiary, Crossroad Fund, Medica Venture Partners, SCPVitalife and Technion Investment Opportunities Fund to establish a European presence and expand ongoing clinical efforts with GelrinC.
More Articles on Orthopedic Devices:
Smith & Nephew CFO to Resign
Recall Issued for Medtronic Infusion Pumps
Ohio Third Frontier Gives $3M to Medical Device Partnership Fund